SCHEMBL448297

SCHEMBL448297

CCCCCCC(C)CC=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADH1B P00325 1/20 0.50
ADH1C P00326 1/20 0.50
ADH1A P07327 1/20 0.50
ADH4 P08319 1/20 0.50
ADH7 P40394 1/20 0.50
ACE2 Q9BYF1 1/20 0.48
TSHR P16473 2/20 0.46
FAAH O00519 2/20 0.41
TRPV1 Q8NER1 1/20 0.41
OPRM1 P35372 1/20 0.41
TRPA1 O75762 1/20 0.39
DDAH1 O94760 1/20 0.39
GAPDH P04406 1/20 0.39
MAPT P10636 1/20 0.39
GPR84 Q9NQS5 3/20 0.39
FDPS P14324 3/20 0.39
SPHK1 Q9NYA1 1/20 0.39
FFAR1 O14842 1/20 0.39
CA1 P00915 1/20 0.39
EPHX1 P07099 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29003461 1.00 ADH1B (0.50) ADH1BADH1CADH1AADH4ADH7
SCHEMBL1067436 1.00 ADH1B (0.50) ADH1BADH1CADH1AADH4ADH7
SCHEMBL9112561 1.00 ADH1B (0.50) ADH1BADH1CADH1AADH4ADH7
SCHEMBL158205 1.00 ADH1B (0.50) ADH1BADH1CADH1AADH4ADH7
SCHEMBL14336196 1.00 ADH1B (0.50) ADH1BADH1CADH1AADH4ADH7
SCHEMBL2925631 1.00 ADH1B (0.50) ADH1BADH1CADH1AADH4ADH7
SCHEMBL13295924 1.00 ADH1B (0.50) ADH1BADH1CADH1AADH4ADH7
SCHEMBL29170277 1.00 ADH1B (0.50) ADH1BADH1CADH1AADH4ADH7
SCHEMBL1409723 0.98 ADH1B (0.47) ADH1BADH1CADH1AADH4ADH7
SCHEMBL22902386 0.98 ADH1B (0.47) ADH1BADH1CADH1AADH4ADH7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 582 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3109254-B1 CROSSLINKED NUCLEOSIDE AND NUCLEOTIDE UNIV OSAKA (JP) 2018-04-11 EP claimed
WO-2016079757-A2 NOVEL PROCESSES FOR PREPARING 5-HYDROXYMETHYL-OXAZOLIDIN-2-ONE DERIVATIVES SYMED LABS LIMITED (IN) 2016-05-26 WO claimed
WO-2014045292-A1 IMPROVED PROCESS FOR THE PREPARATION OF LINEZOLID INTERMEDIATE SYMED LABS LIMITED (IN) 2014-03-27 WO claimed
US-20260096991-A1 BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION XAMPLA LTD (GB) 2026-04-09 US disclosed
EP-4489592-B1 BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION XAMPLA LTD (GB) 2025-12-24 EP disclosed
US-20250255827-A1 BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION XAMPLA LIMITED (GB) 2025-08-14 US disclosed
EP-4593639-A1 BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION Xampla Limited (GB) 2025-08-06 EP disclosed
US-20250186960-A1 BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION XAMPLA LIMITED (GB) 2025-06-12 US disclosed
EP-3888782-B1 COATED MICROCAPSULES NOXELL CORP (US) 2025-06-11 EP disclosed
WO-2025109106-A1 CORE-SHELL MICROCAPSULES XAMPLA Ltd. (GB) 2025-05-30 WO disclosed
EP-4489900-A1 BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION Xampla Limited (GB) 2025-01-15 EP disclosed
EP-0268268-B1 HYDROFORMYLATION USING LOW VOLATILE PHOSPHINE LIGANDS UNION CARBIDE CORPORATION (US) 1992-06-10 EP disclosed
EP-0347596-A2 Bleaching composition INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 1989-12-27 EP disclosed
US-4863631-A Dimethyl substituted alkyl nitriles, perfume and bleach compositions containing same organoleptic uses thereof and process intermediates for producing same INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 1989-09-05 US disclosed
US-4774076-A DENTIFRICES, MOUTHWASHES LION CORPORATION (JP) 1988-09-27 US disclosed
EP-0268268-A2 Hydroformylation using low volatile phosphine ligands UNION CARBIDE CORPORATION (US) 1988-05-25 EP disclosed
US-4731486-A Hydroformylation using low volatile phosphine ligands UNION CARBIDE CORPORATION (US) 1988-03-15 US disclosed
US-4649044-A DISCOLORATION INHIBITION LION CORPORATION (JP) 1987-03-10 US disclosed
US-4208499-A PROTECTIVE COLLOID, CARBONYL GROUP-CONTAINING POLYVINYL ALCOHOL NIPPON GOHSEI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1980-06-17 US disclosed
US-4117110-A GELS, DEODORIZERS GLOBOL WERK GMBH (DE) 1978-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260096991-A1 BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION PCTP, CLK4, MTCL3 ADH1B 4768/4885ADH1C 4340/4885ADH1A 4641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.